Imunon, Inc. — Director's Dealing 2024

Aug 16, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2024-08-16

Reporting Person: Lindborg Stacy (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-15	Imunon Common Stock	P	25000	$0.98	Acquired	264166	Direct

Footnotes

F1: The CEO and president purchased the shares on the open market.